These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


291 related items for PubMed ID: 21170578

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico.
    Salmerón J, Lazcano-Ponce E, Lorincz A, Hernández M, Hernández P, Leyva A, Uribe M, Manzanares H, Antunez A, Carmona E, Ronnett BM, Sherman ME, Bishai D, Ferris D, Flores Y, Yunes E, Shah KV.
    Cancer Causes Control; 2003 Aug; 14(6):505-12. PubMed ID: 12948281
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study.
    Aarnio R, Östensson E, Olovsson M, Gustavsson I, Gyllensten U.
    BMC Cancer; 2020 Jul 13; 20(1):645. PubMed ID: 32660432
    [Abstract] [Full Text] [Related]

  • 6. A pilot study of HPV DNA and cytology testing in 50,159 women in the routine Mexican Social Security Program.
    Lazcano-Ponce E, Lörincz AT, Salmerón J, Fernández I, Cruz A, Hernández P, Mejia I, Hernández-Avila M.
    Cancer Causes Control; 2010 Oct 13; 21(10):1693-700. PubMed ID: 20617376
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.
    Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD.
    J Natl Cancer Inst; 2002 Oct 02; 94(19):1469-83. PubMed ID: 12359856
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua.
    Campos NG, Mvundura M, Jeronimo J, Holme F, Vodicka E, Kim JJ.
    BMJ Open; 2017 Jun 15; 7(6):e015048. PubMed ID: 28619772
    [Abstract] [Full Text] [Related]

  • 15. Improving cervical cancer screening in Mexico: results from the Morelos HPV Study.
    Flores Y, Bishai D, Lazcano E, Shah K, Lörincz A, Hernández M, Salmerón J.
    Salud Publica Mex; 2003 Jun 15; 45 Suppl 3():S388-98. PubMed ID: 14746032
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.